Pyc Therapeutics Ltd has released a press release.
PYCs Lead Drug Effective in Patient Derived Models Tested
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
In the deck
Earlier from PYC Therapeutics
- Second Potential Blockbuster Drug Added to PYCs Pipeline
- Creation of Novel Gene Therapy Delivery Technology
- Appendix 4E Preliminary Final Report
- Executive re-structure across global operations
- Shareholder Update - Forward View 2020 Milestones
Later from PYC Therapeutics
- New Drug for Substantial Unmet Need Added to Pipeline
- PYC Equity Raising to Raise up to $55 Million
- PYC Business and Equity Raising Presentation
- Successful Institutional Entitlement Offer and Placement
- Review of Activities and Appendix 4C
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics